Ulta Beauty Q2 Earnings & Sales Beat Estimates, FY25 Outlook Raised

Ulta Beauty reported strong second-quarter fiscal 2025 results, with EPS of $5.78 and net sales of $2.79 billion, both exceeding analyst estimates and growing year-over-year. This performance was driven by a robust 6.7% increase in comparable sales, fueled by higher transactions and average ticket growth. Consequently, the company raised its full-year fiscal 2025 outlook, now projecting net sales between $12-$12.1 billion and EPS in the range of $23.85-$24.30, signaling management's increased confidence in its operational momentum.

Analysis

Ulta Beauty delivered a significant Q2 fiscal 2025 earnings beat, with EPS of $5.78 surpassing the $5.03 consensus estimate and net sales of $2.79 billion exceeding the expected $2.65 billion. The primary driver was a robust 6.7% increase in comparable sales, which dramatically outperformed the 0.5% market expectation, fueled by a healthy combination of a 3.7% rise in customer transactions and a 2.9% increase in average ticket size. This top-line strength translated into an expanded gross margin, which grew to 39.2% from 38.3% year-over-year due to improved merchandise margins and lower inventory shrinkage. However, this was partially offset by a 15% increase in SG&A expenses, leading to a slight operating margin contraction to 12.4% from 12.9% YoY, though this figure still came in well ahead of the 10.8% anticipated by analysts. In response to the strong performance, management substantially raised its full-year 2025 guidance, now projecting net sales of $12-$12.1 billion and comparable sales growth of 2.5%-3.5%. While the raised EPS guidance of $23.85-$24.30 is a clear positive signal, it notably remains below the $25.34 EPS reported in fiscal 2024, indicating that margin pressures persist despite the strong sales momentum. The stock's 12.5% gain over the past three months has also lagged the industry's 23.2% growth, suggesting these strong results were not fully priced in.

Key Decisions for Investors

• Investors should view the significant beat and raised guidance as a challenge to the market's prior pessimism, suggesting Ulta's consumer base is more resilient than anticipated.
• Monitor operating margin performance closely, as the guided full-year range of 11.9%-12.0% and the EPS projection both sit below prior-year levels, representing the key risk factor amid strong sales growth.
• Consider that the stock's recent underperformance relative to its industry peers, combined with a strong fundamental surprise, may present a tactical opportunity for alpha.
• Factor the company's commitment to a nearly $900 million share buyback for fiscal 2025 into valuation models, as it provides a strong support for EPS and shareholder returns.